高级检索
当前位置: 首页 > 详情页

6-Gingerol exerts a protective effect against hypoxic injury through the p38/Nrf2/HO-1 and p38/NF-κB pathway in H9c2 cells.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China [2]Hebei Higher Education Institute Applied Technology Research Center on TCM Formula Preparation, Shijiazhuang, Hebei, China [3]The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China [4]Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Shijiazhuang, Hebei, China [5]School of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China [6]Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China
出处:
ISSN:

摘要:
Ginger, one of the most widely consumed condiment for various foods and beverages, has many pharmacological effects. 6-gingerol, a naturally occurring phenol, is one of the major pungent constituents of ginger. The purpose of this study was to characterize the effect of 6-gingerol on the p38/Nrf2/HO-1 and p38/NF-κB signaling pathway, as a possible means of combating hypoxia-related oxidative stress. H9c2 cells were chemically induced with CoCl2 to mimic hypoxia-associated cellular damage. Cardiomyocyte injury was assessed by lactate dehydrogenase and creatine kinase. Reactive oxygen species production was assessed by 2',7'-dichlorodihydrofluorescein diacetate. The antioxidative property of 6-gingerol was measured by estimating the activities of superoxide dismutase, catalase, glutathione and glutathione disulfide. Apoptosis was detected by flow cytometry after Annexin V-FITC-propidium iodide double staining. Western blotting was used to evaluate levels of p-p38, p38, cytoplasm p65, nuclear p65, total p65, nuclear Nrf2, total Nrf2, Keap1, HIF-1α, and HO-1. 6-gingerol was able to counter hypoxia-induced cardiomyocyte injury as evidenced by inhibiting the levels of oxidative stress indexes and increasing the percentage of apoptosis. Furthermore, 6-gingerol was able to down-regulate p-p38/p38, nuclear p65, total p65 and Keap1 expression induced by CoCl2 stimulation and increased cytoplasm p65, nuclear Nrf2, total Nrf2, HO-1, and HIF-1α expression. However, treatment with specific Nrf2 inhibitor blunted the activation of Nrf2 signaling and removed the protective effects of 6-gingerol. These experiments provide evidence that 6-gingerol exerts cytoprotective effects, which may be associated with the regulation of oxidative stress and apoptosis, potentially through activating the Nrf2 pathway and inhibiting the p38/NF-κB pathways.Copyright © 2022. Published by Elsevier Inc.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2022]版:
大类 | 2 区 医学
小类 | 1 区 营养学 2 区 生化与分子生物学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 2 区 营养学
JCR分区:
出版当年[2022]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 NUTRITION & DIETETICS
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China [2]Hebei Higher Education Institute Applied Technology Research Center on TCM Formula Preparation, Shijiazhuang, Hebei, China
共同第一作者:
通讯作者:
通讯机构: [1]School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China [4]Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Shijiazhuang, Hebei, China [5]School of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China [6]Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China [*1]School of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China. [*2]Affiliated Hospital, Hebei Uni- versity of Chinese Medicine, Shijiazhuang, Hebei 050200, China. [*3]School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号